Epidemiological correlations between active malignancy (AM) and acute ischemic stroke (AIS) are well-established. However, the effect of reperfusion strategies, particularly mechanical thrombectomy (MT), has been barely investigated in patients with AIS and AM. We aim to evaluate safety and efficacy of reperfusion strategies in such patients.
Sallustio, F., Mascolo, A.p., Marrama, F., Koch, G., Alemseged, F., Davoli, A., et al. (2019). Safety and Efficacy of Reperfusion Therapies for Acute Ischemic Stroke Patients With Active Malignancy. JOURNAL OF STROKE AND CEREBROVASCULAR DISEASES, 28(8), 2287-2291 [10.1016/j.jstrokecerebrovasdis.2019.05.018].
Safety and Efficacy of Reperfusion Therapies for Acute Ischemic Stroke Patients With Active Malignancy
Davoli A.;Da Ros V.;Morosetti D.;Diomedi M.
2019-08-01
Abstract
Epidemiological correlations between active malignancy (AM) and acute ischemic stroke (AIS) are well-established. However, the effect of reperfusion strategies, particularly mechanical thrombectomy (MT), has been barely investigated in patients with AIS and AM. We aim to evaluate safety and efficacy of reperfusion strategies in such patients.| File | Dimensione | Formato | |
|---|---|---|---|
|
2019 Safety and Efficacy of Reperfusion Therapies for Acute IschemicStroke Patients with Active Malignancy.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
70.09 kB
Formato
Adobe PDF
|
70.09 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
